• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾髓质癌的影像学检查

Imaging of Renal Medullary Carcinoma.

作者信息

Greco Federico, Faiella Eliodoro, Santucci Domiziana, Mallio Carlo Augusto, Nezzo Marco, Quattrocchi Carlo Cosimo, Beomonte Zobel Bruno, Grasso Rosario Francesco

机构信息

Unit of Diagnostic Imaging, Università Campus Bio-Medico di Roma, Rome, Italy.

出版信息

J Kidney Cancer VHL. 2017 Mar 21;4(1):1-7. doi: 10.15586/jkcvhl.2017.62. eCollection 2017.

DOI:10.15586/jkcvhl.2017.62
PMID:28405543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5364331/
Abstract

Renal medullary carcinoma (RMC) is a rare, highly aggressive tumor recognized as an independent pathological entity. African-descent adolescents and young adults with sickle cell hemoglobinopathy are the most affected groups. This rare subtype of renal cell carcinoma has its own morphogenetic and pathological characteristics. The major clinical manifestations include gross hematuria, abdominal or flank pain, and weight loss. The prognosis is very poor, with 95% of cases diagnosed at an advanced stage of the disease. In this review, we summarize the morphologic and dynamic characteristics of RMC under various imaging modalities such as ultrasound, computed tomography, and magnetic resonance. Differential diagnosis and management strategies are also discussed.

摘要

肾髓质癌(RMC)是一种罕见的、侵袭性很强的肿瘤,被认为是一种独立的病理实体。患有镰状细胞血红蛋白病的非洲裔青少年和年轻人是受影响最严重的群体。这种罕见的肾细胞癌亚型有其自身的形态发生和病理特征。主要临床表现包括肉眼血尿、腹部或侧腹痛以及体重减轻。预后非常差,95%的病例在疾病晚期被诊断出来。在本综述中,我们总结了肾髓质癌在超声、计算机断层扫描和磁共振等各种成像模式下的形态和动态特征。还讨论了鉴别诊断和管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/5364331/a76f1fcff783/jkcvhl-4-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/5364331/a76f1fcff783/jkcvhl-4-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/5364331/a76f1fcff783/jkcvhl-4-1-g001.jpg

相似文献

1
Imaging of Renal Medullary Carcinoma.肾髓质癌的影像学检查
J Kidney Cancer VHL. 2017 Mar 21;4(1):1-7. doi: 10.15586/jkcvhl.2017.62. eCollection 2017.
2
Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients.肾髓质癌患者的临床特征、治疗及预后:135例患者的单中心回顾性分析
Eur Urol Oncol. 2025 Apr;8(2):315-323. doi: 10.1016/j.euo.2024.07.002. Epub 2024 Jul 15.
3
Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.肾细胞癌,未分类,具有髓样表型:与肾髓样癌重叠的低分化腺癌。
Hum Pathol. 2017 Sep;67:134-145. doi: 10.1016/j.humpath.2017.07.006. Epub 2017 Jul 15.
4
Unusual Presentation of Renal Medullary Carcinoma With Undiagnosed Sickle Cell Trait.伴有未诊断出的镰状细胞性状的肾髓质癌的不寻常表现。
Cureus. 2020 Sep 30;12(9):e10731. doi: 10.7759/cureus.10731.
5
Renal medullary carcinoma: unsuspected diagnosis at stone protocol CT.
Emerg Radiol. 2007 Sep;14(4):245-7. doi: 10.1007/s10140-007-0596-y. Epub 2007 Apr 4.
6
Renal medullary carcinoma in a six-year-old boy with sickle cell trait.一名患有镰状细胞性状的6岁男孩的肾髓质癌。
Pathol Oncol Res. 2003;9(3):193-5. doi: 10.1007/BF03033737. Epub 2003 Oct 7.
7
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.肾髓质癌患者的诊断、治疗和临床试验资格标准的更新建议。
Clin Genitourin Cancer. 2019 Feb;17(1):1-6. doi: 10.1016/j.clgc.2018.09.005. Epub 2018 Sep 12.
8
Renal Medullary Carcinoma and Sickle Cell Trait: A Push for Early Diagnosis and Intervention Report of Two Cases.肾髓质癌合并镰状细胞特征:推动早期诊断和干预的报告 两例报告。
J Natl Med Assoc. 2017;109(1):63-65. doi: 10.1016/j.jnma.2016.08.006. Epub 2016 Sep 7.
9
Renal medullary carcinoma in a white adolescent with sickle cell trait.一名患有镰状细胞性状的白人青少年患肾髓质癌。
J Pediatr Hematol Oncol. 2014 Jul;36(5):e285-9. doi: 10.1097/MPH.0000000000000118.
10
Renal Medullary Carcinoma.肾髓质癌。
Arch Pathol Lab Med. 2019 Dec;143(12):1556-1561. doi: 10.5858/arpa.2017-0492-RS. Epub 2019 Mar 11.

引用本文的文献

1
Computed tomography and magnetic resonance imaging characteristics of renal cell carcinoma: Differences between subtypes and clinical evaluation.肾细胞癌的计算机断层扫描和磁共振成像特征:亚型之间的差异及临床评估
J Clin Imaging Sci. 2025 Feb 25;15:10. doi: 10.25259/JCIS_160_2024. eCollection 2025.
2
Diagnostic challenges of renal medullary carcinoma and the role for cytologic assessment: Case report and literature review.肾髓质癌的诊断挑战及细胞学评估的作用:病例报告及文献复习。
J Clin Lab Anal. 2023 Apr;37(4):e24854. doi: 10.1002/jcla.24854. Epub 2023 Feb 26.
3
Decreased cross-sectional muscle area in male patients with clear cell renal cell carcinoma and peritumoral collateral vessels.

本文引用的文献

1
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.肾髓质癌患者的管理与预后:一项多中心协作研究。
BJU Int. 2017 Dec;120(6):782-792. doi: 10.1111/bju.13705. Epub 2016 Dec 9.
2
Diagnostic performance of contrast-enhanced ultrasound in the evaluation of renal masses in patients with renal impairment.超声造影在评估肾功能损害患者肾肿块中的诊断性能。
Med J Malaysia. 2016 Aug;71(4):193-198.
3
Clinical and computed tomography imaging features of renal medullary carcinoma: A report of six cases.
透明细胞肾细胞癌伴瘤旁侧支血管男性患者的肌肉横截面积减小。
World J Radiol. 2022 Apr 28;14(4):82-90. doi: 10.4329/wjr.v14.i4.82.
4
Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma.吉西他滨联合多柔比星治疗肾髓质癌的疗效和安全性。
Clin Genitourin Cancer. 2021 Dec;19(6):e401-e408. doi: 10.1016/j.clgc.2021.08.007. Epub 2021 Sep 15.
5
Renal Medullary Carcinoma in an Adolescent With Unknown Sickle Cell Trait.一名患有未知镰状细胞性状的青少年的肾髓质癌
Cureus. 2021 Apr 13;13(4):e14473. doi: 10.7759/cureus.14473.
6
Renal medullary carcinoma and its association with sickle cell trait: a case report and literature review.肾髓质癌及其与镰状细胞性状的关联:一例报告及文献综述。
Curr Oncol. 2020 Feb;27(1):e53-e56. doi: 10.3747/co.27.5043. Epub 2020 Feb 1.
肾髓质癌的临床及计算机断层扫描影像特征:6例报告
Oncol Lett. 2016 Jan;11(1):261-266. doi: 10.3892/ol.2015.3891. Epub 2015 Nov 9.
4
SMARCB1/INI1 Genetic Alterations in Renal Medullary Carcinomas.肾髓质癌中的SMARCB1/INI1基因改变
Eur Urol. 2016 Jun;69(6):1062-4. doi: 10.1016/j.eururo.2016.01.002. Epub 2016 Jan 15.
5
Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas.平衡易位破坏 SMARCB1 是肾髓质癌中标志性的复发性遗传改变。
Eur Urol. 2016 Jun;69(6):1055-61. doi: 10.1016/j.eururo.2015.09.027. Epub 2015 Oct 1.
6
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling.全面基因组分析评估的肾集合管癌临床病例特征。
Eur Urol. 2016 Sep;70(3):516-21. doi: 10.1016/j.eururo.2015.06.019. Epub 2015 Jul 3.
7
Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity.集合管癌与肾髓质癌:对疾病分类学和生物学清晰度的呼吁。
Am J Surg Pathol. 2014 Jul;38(7):871-4. doi: 10.1097/PAS.0000000000000222.
8
Beyond renal cell carcinoma: rare and unusual renal masses.肾细胞癌之外:罕见及不寻常的肾脏肿块
Abdom Imaging. 2012 Oct;37(5):873-84. doi: 10.1007/s00261-012-9903-5.
9
Evaluation of renal masses with contrast-enhanced ultrasound: initial experience.增强超声评估肾肿块:初步经验。
AJR Am J Roentgenol. 2011 Oct;197(4):897-906. doi: 10.2214/AJR.10.6330.
10
The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses.对比增强超声(CEUS)在肾脏肿块患者特征描述中的价值。
Clin Hemorheol Microcirc. 2010;46(4):275-90. doi: 10.3233/CH-2010-1352.